5H,6H,7H,8H-(1,2,4)triazolo(4,3-a)pyrazine → HCID 58117148, compound

HRID 2066522Notes

Reaction equation

HRID 2066522 reaction equation
[Cl:1][C:2]1[N:3]=[C:4]([N:21]2[CH2:26][CH2:25][O:24][CH2:23][CH2:22]2)[C:5]2[S:10][C:9]([CH2:11][N:12]3[CH2:17][CH2:16][NH:15][C:14](=O)[C:13]3([CH3:20])C)=[CH:8][C:6]=2[N:7]=1.[N:27]1[N:28]=CN2CCNCC=12>>[Cl:1][C:2]1[N:3]=[C:4]([N:21]2[CH2:26][CH2:25][O:24][CH2:23][CH2:22]2)[C:5]2[S:10][C:9]([CH2:11][N:12]3[CH2:17][CH2:16][N:15]4[CH:14]=[N:27][N:28]=[C:20]4[CH2:13]3)=[CH:8][C:6]=2[N:7]=1

Participants

3

Procedure

Prepared according to the method used in the preparation of 4-(2-chloro-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-6-ylmethyl)-3,3-dimethyl-piperazin-2-one using 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine in place of 3,3-dimethyl-piperazin-2-one. The title compound was obtained as a white solid (115 mg, 84%).

Workup

  1. customPrepared

Sources & evidence

ORD record
ord-2d684e1ea75142119c76855a25797c8a
Source dataset
uspto-grants-2012_10
Patent number
US08293735B2

Reaction notes

Loading…